HIGH TIDE INC (HITI) Stock Fundamental Analysis

USA Nasdaq NASDAQ:HITI • CA42981E4013

2.27 USD
-0.06 (-2.58%)
Last: Feb 5, 2026, 04:10 PM
Fundamental Rating

4

Taking everything into account, HITI scores 4 out of 10 in our fundamental rating. HITI was compared to 191 industry peers in the Pharmaceuticals industry. HITI has a medium profitability rating, but doesn't score so well on its financial health evaluation. HITI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year HITI has reported negative net income.
  • In the past year HITI had a positive cash flow from operations.
  • HITI had negative earnings in each of the past 5 years.
  • HITI had a positive operating cash flow in 4 of the past 5 years.
HITI Yearly Net Income VS EBIT VS OCF VS FCFHITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • HITI's Return On Assets of -14.54% is fine compared to the rest of the industry. HITI outperforms 62.83% of its industry peers.
  • HITI has a Return On Equity (-57.92%) which is comparable to the rest of the industry.
  • With an excellent Return On Invested Capital value of 5.17%, HITI belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROIC 5.17%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
HITI Yearly ROA, ROE, ROICHITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • The Operating Margin of HITI (2.74%) is better than 78.01% of its industry peers.
  • HITI's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 25.99%, HITI perfoms like the industry average, outperforming 54.97% of the companies in the same industry.
  • HITI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.74%
PM (TTM) N/A
GM 25.99%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
HITI Yearly Profit, Operating, Gross MarginsHITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HITI is destroying value.
  • HITI has more shares outstanding than it did 1 year ago.
  • HITI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, HITI has a worse debt to assets ratio.
HITI Yearly Shares OutstandingHITI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
HITI Yearly Total Debt VS Total AssetsHITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • HITI has an Altman-Z score of 1.59. This is a bad value and indicates that HITI is not financially healthy and even has some risk of bankruptcy.
  • HITI has a Altman-Z score (1.59) which is comparable to the rest of the industry.
  • HITI has a debt to FCF ratio of 8.31. This is a slightly negative value and a sign of low solvency as HITI would need 8.31 years to pay back of all of its debts.
  • HITI's Debt to FCF ratio of 8.31 is amongst the best of the industry. HITI outperforms 80.63% of its industry peers.
  • HITI has a Debt/Equity ratio of 0.94. This is a neutral value indicating HITI is somewhat dependend on debt financing.
  • HITI has a Debt to Equity ratio of 0.94. This is in the lower half of the industry: HITI underperforms 72.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Altman-Z 1.59
ROIC/WACC0.56
WACC9.21%
HITI Yearly LT Debt VS Equity VS FCFHITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that HITI should not have too much problems paying its short term obligations.
  • HITI has a worse Current ratio (1.37) than 73.30% of its industry peers.
  • A Quick Ratio of 0.70 indicates that HITI may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.70, HITI is doing worse than 85.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.7
HITI Yearly Current Assets VS Current LiabilitesHITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

  • HITI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -884.13%.
  • Looking at the last year, HITI shows a quite strong growth in Revenue. The Revenue has grown by 13.72% in the last year.
  • HITI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.14% yearly.
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%

3.2 Future

  • HITI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.45% yearly.
  • HITI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.96% yearly.
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue Next Year29.67%
Revenue Next 2Y19.93%
Revenue Next 3Y18.21%
Revenue Next 5Y13.96%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HITI Yearly Revenue VS EstimatesHITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
HITI Yearly EPS VS EstimatesHITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HITI. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 23.25, HITI is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HITI indicates a somewhat cheap valuation: HITI is cheaper than 75.39% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, HITI is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 23.25
HITI Price Earnings VS Forward Price EarningsHITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HITI is valued cheaply inside the industry as 90.58% of the companies are valued more expensively.
  • 84.82% of the companies in the same industry are more expensive than HITI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.46
EV/EBITDA 8.36
HITI Per share dataHITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • HITI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HITI's earnings are expected to grow with 46.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.32%
EPS Next 3Y46.8%

0

5. Dividend

5.1 Amount

  • HITI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HIGH TIDE INC

NASDAQ:HITI (2/5/2026, 4:10:12 PM)

2.27

-0.06 (-2.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)03-16
Inst Owners13.66%
Inst Owner Change0.16%
Ins Owners8.85%
Ins Owner ChangeN/A
Market Cap198.06M
Revenue(TTM)593.99M
Net Income(TTM)-50.75M
Analysts80
Price Target5.34 (135.24%)
Short Float %0.35%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.04%
Min Revenue beat(2)0.98%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.13%
Revenue beat(12)9
Avg Revenue beat(12)0.97%
Revenue beat(16)13
Avg Revenue beat(16)7.41%
PT rev (1m)-0.88%
PT rev (3m)-0.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)14.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.25
P/S 0.46
P/FCF 20.46
P/OCF 11.33
P/B 3.09
P/tB N/A
EV/EBITDA 8.36
EPS(TTM)-0.45
EYN/A
EPS(NY)0.1
Fwd EY4.3%
FCF(TTM)0.11
FCFY4.89%
OCF(TTM)0.2
OCFY8.83%
SpS4.99
BVpS0.74
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROCE 6.54%
ROIC 5.17%
ROICexc 6.4%
ROICexgc 17.98%
OM 2.74%
PM (TTM) N/A
GM 25.99%
FCFM 2.23%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.85%
ROICexc growth 3YN/A
ROICexc growth 5Y9.97%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
F-Score2
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Debt/EBITDA 2.03
Cap/Depr 43.8%
Cap/Sales 1.79%
Interest Coverage 2.21
Cash Conversion 58.77%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.7
Altman-Z 1.59
F-Score2
WACC9.21%
ROIC/WACC0.56
Cap/Depr(3y)33.59%
Cap/Depr(5y)35.25%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%
Revenue Next Year29.67%
Revenue Next 2Y19.93%
Revenue Next 3Y18.21%
Revenue Next 5Y13.96%
EBIT growth 1Y6.44%
EBIT growth 3YN/A
EBIT growth 5Y64.03%
EBIT Next Year707.98%
EBIT Next 3Y142.78%
EBIT Next 5Y80.76%
FCF growth 1Y-48.76%
FCF growth 3YN/A
FCF growth 5Y16.8%
OCF growth 1Y-32.86%
OCF growth 3Y74.46%
OCF growth 5Y21.95%

HIGH TIDE INC / HITI FAQ

What is the fundamental rating for HITI stock?

ChartMill assigns a fundamental rating of 4 / 10 to HITI.


What is the valuation status for HITI stock?

ChartMill assigns a valuation rating of 5 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.


Can you provide the profitability details for HIGH TIDE INC?

HIGH TIDE INC (HITI) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for HITI stock?

The Earnings per Share (EPS) of HIGH TIDE INC (HITI) is expected to grow by 121.5% in the next year.